(S)-1-(4-Phenyl-1H-imidazol-2-yl)ethanamine, 95.0%, 5g

1-Bromo-2-(difluoromethyl)-4-nitrobenzene, 98%, 500mg

Methyl 5-hydroxy-6-methoxynicotinate, 95.0%, 100mg

1-Butanol, min 99.5%, for synthesis, 1L, glass packaging

1,1-Difluoro-6-azaspiro[3.4]octane hydrochloride, 98%, 100mg

4-((9H-Fluoren-9-yl)methyl) 1-(tert-butyl) 2-hydroxypiperazine-1,4-dicarboxylate, 97%, 250mg

Methyl 4-fluoro-3-methoxybenzoate, 98%, 5g

3-Bromo-2-chloro-4-methoxypyridine, 95.0%, 25g

2-(1-Pyrrolyl)benzylamine, 95.0%, 5g

(2R)-2-amino-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid, 97%, 5g

Methyl 2-amino-5-(trifluoromethyl)nicotinate, 98+%, 10g

N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-pyrazolo[3,4-b]pyridine-4-carboxamide, 97%, 25mg

6-FLUORO-3-IODO-1H-INDAZOLE, 95%, 250mg